{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:57:49Z","timestamp":1787317069090,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":46,"publisher":"Springer US","isbn-type":[{"value":"9781071644577","type":"print"},{"value":"9781071644584","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4458-4_2","type":"book-chapter","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:36:28Z","timestamp":1744950988000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Features of Human Infection by Yellow Fever"],"prefix":"10.1007","author":[{"given":"Isabel","family":"de F\u00e1tima Alvim Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Zelkcovicz","family":"Ertler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana Napole\u00e3o","family":"Cozendey-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Waismann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Gomes","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"2_CR1","volume-title":"Guia de vigil\u00e2ncia epidemiol\u00f3gica","author":"Funda\u00e7\u00e3o Nacional de Sa\u00fade (Brazil)","year":"2002","unstructured":"Funda\u00e7\u00e3o Nacional de Sa\u00fade (Brazil) (2002) Guia de vigil\u00e2ncia epidemiol\u00f3gica, 5th edn. FUNASA","edition":"5"},{"key":"2_CR2","volume-title":"Manual de Vigil\u00e2ncia Epidemiol\u00f3gica da Febre Amarela","author":"V Epidemiol\u00f3gica","year":"1999","unstructured":"Epidemiol\u00f3gica V (1999) Manual de Vigil\u00e2ncia Epidemiol\u00f3gica da Febre Amarela. Minist\u00e9rio da Sa\u00fade: Funda\u00e7\u00e3o Nacional de Sa\u00fade, Bras\u00edlia"},{"issue":"2","key":"2_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/0049475517699726","volume":"47","author":"QA Ahmed","year":"2017","unstructured":"Ahmed QA, Memish ZA (2017) Yellow fever from Angola and Congo: a storm gathers. Trop Dr 47(2):92\u201396. https:\/\/doi.org\/10.1177\/0049475517699726","journal-title":"Trop Dr"},{"issue":"2","key":"2_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1590\/S0037-86822003000200012","volume":"36","author":"PFC Vasconcelos","year":"2003","unstructured":"Vasconcelos PFC (2003) Febre amarela. Rev Soc Bras Med Trop 36(2):275\u2013293","journal-title":"Rev Soc Bras Med Trop"},{"issue":"5","key":"2_CR5","first-page":"130","volume":"59","author":"CDC","year":"2010","unstructured":"CDC (2010) Transmission of yellow fever vaccine virus through breast-feeding \u2013 Brazil, 2009. MMWR. Morb Mortal Wkly Rep 59(5):130\u2013132","journal-title":"Morb Mortal Wkly Rep"},{"issue":"9","key":"2_CR6","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3201\/eid1709.110242","volume":"17","author":"MR Bentlin","year":"2011","unstructured":"Bentlin MR, de Barros Almeida RAM, Coelho KIR, Ribeiro AF, Siciliano MM, Suzuki A, Fortaleza CMCB (2011) Perinatal transmission of yellow fever, Brazil, 2009. Emerg Infect Dis 17(9):1779","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4269\/ajtmh.2010.09-0782","volume":"83","author":"MA Johansson","year":"2010","unstructured":"Johansson MA et al (2010) Incubation periods of yellow fever virus. Am J Trop Med Hyg 83(1):183\u2013188. https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0782","journal-title":"Am J Trop Med Hyg"},{"key":"2_CR8","doi-asserted-by":"publisher","unstructured":"Tabile PM et al (2014) Perfil Cl\u00ednico E Epidemiol\u00f3gico Da Febre Amarela Em Santa Cruz Do Sul (Rs): Surto De 2009. p. 12. In: S\u00e3o Paulo: Blucher. ISSN 2357-7282, https:\/\/doi.org\/10.5151\/medpro-II-cbmh-003","DOI":"10.5151\/medpro-II-cbmh-003"},{"issue":"5","key":"2_CR9","doi-asserted-by":"publisher","first-page":"taz040","DOI":"10.1093\/jtm\/taz040","volume":"26","author":"YL Ho","year":"2019","unstructured":"Ho YL et al (2019) Hospital das Cl\u00ednicas yellow fever assistance group. Severe yellow fever in Brazil: clinical characteristics and management. J Travel Med 26(5):taz040. https:\/\/doi.org\/10.1093\/jtm\/taz040","journal-title":"J Travel Med"},{"issue":"4","key":"2_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/14760584.4.4.553","volume":"4","author":"TP Monath","year":"2005","unstructured":"Monath TP (2005) Yellow fever vaccine. Expert Rev Vaccines 4(4):553\u2013574. https:\/\/doi.org\/10.1586\/14760584.4.4.553","journal-title":"Expert Rev Vaccines"},{"key":"2_CR11","unstructured":"Minist\u00e9rio da Sa\u00fade (Brazil) (2004) Manual de Vigil\u00e2ncia Epidemiol\u00f3gica de Febre Amarela. Bras\u00edlia"},{"key":"2_CR12","unstructured":"Minist\u00e9rio da Sa\u00fade (Brazil) (2018) Febre Amarela: Guia para Profissionais de Sa\u00fade (1st ed. atualizada). Bras\u00edlia"},{"key":"2_CR13","unstructured":"CDC (2019) Yellow fever home. Centers for Disease Control and Prevention"},{"issue":"7","key":"2_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00152193-200507000-00061","volume":"35","author":"B Scheef","year":"2005","unstructured":"Scheef B (2005) Yellow fever. Microbe of the month. Nursing 35(7):75","journal-title":"Nursing"},{"key":"2_CR15","unstructured":"Mour\u00e3o MPG, Lacerda MVG (Sem data). Febre Amarela. Amazonas"},{"issue":"11","key":"2_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027207","volume":"9","author":"C Figueiredo-Mello","year":"2019","unstructured":"Figueiredo-Mello C et al (2019) Efficacy of sofosbuvir as treatment for yellow fever: protocol for a randomised controlled trial in Brazil (SOFFA study). BMJ Open 9(11):e027207. https:\/\/doi.org\/10.1136\/bmjopen-2018-027207","journal-title":"BMJ Open"},{"issue":"2","key":"2_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.actatropica.2005.03.003","volume":"94","author":"JA Quaresma","year":"2005","unstructured":"Quaresma JA et al (2005) Reconsideration of histopathology and ultrastructural aspects of the human liver in yellow fever. Acta Trop 94(2):116\u2013127. https:\/\/doi.org\/10.1016\/j.actatropica.2005.03.003","journal-title":"Acta Trop"},{"issue":"1","key":"2_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.virol.2005.09.058","volume":"345","author":"JA Quaresma","year":"2006","unstructured":"Quaresma JA et al (2006) Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity. Virology 345(1):22\u201330. https:\/\/doi.org\/10.1016\/j.virol.2005.09.058","journal-title":"Virology"},{"key":"2_CR19","unstructured":"Carvalho MLG (2019) Avalia\u00e7\u00e3o da resposta Th17 em amostras hep\u00e1ticas na infec\u00e7\u00e3o humana fatal pelo v\u00edrus da febre amarela (Master\u2019s thesis). Instituto Evandro Chagas. Programa de P\u00f3s-gradua\u00e7\u00e3o em Virologia, Ananindeua"},{"key":"2_CR20","unstructured":"Manejo Cl\u00ednico da Febre Amarela (2017) Minas Gerais"},{"issue":"2","key":"2_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1590\/S0037-86822006000200014","volume":"39","author":"LTM Figueiredo","year":"2006","unstructured":"Figueiredo LTM (2006) Febres hemorr\u00e1gicas por v\u00edrus no Brasil. Rev Soc Bras Med Trop 39(2):203\u2013210. https:\/\/doi.org\/10.1590\/S0037-86822006000200014","journal-title":"Rev Soc Bras Med Trop"},{"key":"2_CR22","unstructured":"Centro Nacional de Epidemiologia (Brazil) (2010) Doen\u00e7as Infecciosas e Parasit\u00e1rias: Guia de Bolso, 8th edn, Bras\u00edlia"},{"key":"2_CR23","unstructured":"Brasil. Doen\u00e7a de Chagas. (Sem data). Tocantins"},{"issue":"3","key":"2_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1590\/S1415-790X2002000300004","volume":"5","author":"PFC Vasconcelos","year":"2002","unstructured":"Vasconcelos PFC (2002) Febre amarela: reflex\u00f5es sobre a doen\u00e7a, as perspectivas para o s\u00e9culo XXI e o risco da reurbaniza\u00e7\u00e3o. Rev Bras Epidemiol 5(3):244\u2013258","journal-title":"Rev Bras Epidemiol"},{"issue":"3","key":"2_CR25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5123\/S1679-49742016000300009","volume":"25","author":"LD Saad","year":"2016","unstructured":"Saad LD, Barata RB (2016) Yellow fever outbreaks in S\u00e3o Paulo state, Brazil, 2000-2010. Epidemiologia e Servi\u00e7os de Sa\u00fade 25(3):531\u2013540. https:\/\/doi.org\/10.5123\/S1679-49742016000300009","journal-title":"Epidemiologia e Servi\u00e7os de Sa\u00fade"},{"issue":"3","key":"2_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002740","volume":"8","author":"AP Romano","year":"2014","unstructured":"Romano AP et al (2014) Yellow fever outbreaks in unvaccinated populations, Brazil, 2008-2009. PLoS Negl Trop Dis 8(3):e2740. https:\/\/doi.org\/10.1371\/journal.pntd.0002740","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1590\/s0037-86822009000500009","volume":"42","author":"M Ribeiro","year":"2009","unstructured":"Ribeiro M, Antunes CM (2009) Yellow fever: study of an outbreak. Rev Soc Bras Med Trop 42(5):523\u2013531. https:\/\/doi.org\/10.1590\/s0037-86822009000500009","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"2_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trstmh.2006.04.001","volume":"101","author":"SH Tuboi","year":"2007","unstructured":"Tuboi SH et al (2007) Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998-2002. Trans R Soc Trop Med Hyg 101(2):169\u2013175. https:\/\/doi.org\/10.1016\/j.trstmh.2006.04.001","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"2_CR29","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S1473-3099(19)30125-2","volume":"19","author":"EG Kallas","year":"2019","unstructured":"Kallas EG et al (2019) Predictors of mortality in patients with yellow fever: an observational cohort study. Lancet Infect Dis 19(7):750\u2013758. https:\/\/doi.org\/10.1016\/S1473-3099(19)30125-2","journal-title":"Lancet Infect Dis"},{"key":"2_CR30","unstructured":"OPS (1987) Situacion actual de la fiebre amarilla: Memorandum de una r\u00e9union de la OPS. IRIS. Boletim de la Oficina Sanitaria Panamericana 102(4)"},{"key":"2_CR31","doi-asserted-by":"publisher","unstructured":"Safadi MAP (2017) Nota informativa sobre a febre amarela. https:\/\/doi.org\/10.13140\/RG.2.2.13903.69285","DOI":"10.13140\/RG.2.2.13903.69285"},{"issue":"10","key":"2_CR32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S1473-3099(19)30478-5","volume":"19","author":"P Ichai","year":"2019","unstructured":"Ichai P et al (2019) Early N-acetylcysteine for hospitalized patients with yellow fever. Lancet Infect Dis 19(10):1055. https:\/\/doi.org\/10.1016\/S1473-3099(19)30478-5","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007072","volume":"13","author":"CS de Freitas","year":"2019","unstructured":"de Freitas CS et al (2019) Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo. PLoS Negl Trop Dis 13(1):e0007072. https:\/\/doi.org\/10.1371\/journal.pntd.0007072","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4269\/ajtmh.19-0219","volume":"101","author":"J SztaJnbok","year":"2019","unstructured":"SztaJnbok J et al (2019) Severe yellow fever and extreme hyperferritinemia managed with therapeutic plasma exchange. Am J Trop Med Hyg 101(3):705\u2013707. https:\/\/doi.org\/10.4269\/ajtmh.19-0219","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"2_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.24862\/cco.v13i1.913","volume":"13","author":"FD Freire","year":"2018","unstructured":"Freire FD et al (2018) Febre amarela: uma velha doen\u00e7a, mas com novos desafios. Conex\u00e3o Ci\u00eancia 13(1):79\u201386","journal-title":"Conex\u00e3o Ci\u00eancia"},{"issue":"5","key":"2_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1056\/NEJMoa2000226","volume":"383","author":"JG Low","year":"2020","unstructured":"Low JG et al (2020) Phase 1 trial of a therapeutic anti-yellow fever virus human antibody. N Engl J Med 383(5):452\u2013459. https:\/\/doi.org\/10.1056\/NEJMoa2000226","journal-title":"N Engl J Med"},{"key":"2_CR37","unstructured":"Bandeira ACA, Brito JDU, Vieira LMRN (2018) Febre Amarela em Pacientes Adultos. Manejo Imediato das Formas Cl\u00ednicas. In Sociedade Brasileira de Infectologia"},{"key":"2_CR38","unstructured":"Fluxograma de abordagem inicial de pacientes com suspeita de febre amarela. Programa Conex\u00e3o Sa\u00fade RJ. Secretaria de Sa\u00fade. Rio de Janeiro"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"473170","DOI":"10.1155\/2014\/473170","volume":"2014","author":"AC Oliveira","year":"2014","unstructured":"Oliveira AC et al (2014) Occurrence of autoimmune diseases related to the vaccine against yellow fever. Autoimmune Dis 2014:473170. https:\/\/doi.org\/10.1155\/2014\/473170","journal-title":"Autoimmune Dis"},{"key":"2_CR40","unstructured":"Sociedade Brasileira de Pediatria (2020, April) Calend\u00e1rio de Vacina\u00e7\u00e3o da SBP 2020. Documento Cient\u00edfico. Departamento de Imuniza\u00e7\u00f5es e Departamento de Infectologia (2019\u20132021)"},{"issue":"48","key":"2_CR41","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1016\/j.vaccine.2019.09.051","volume":"37","author":"TG de Noronha","year":"2019","unstructured":"de Noronha TG et al (2019) Collaborative Group for Studies of yellow fever vaccine. Duration of post-vaccination humoral immunity against yellow fever in children. Vaccine 37(48):7147\u20137154. https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.051","journal-title":"Vaccine"},{"issue":"16","key":"2_CR42","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1016\/j.vaccine.2007.01.078","volume":"25","author":"GC Fernandes","year":"2007","unstructured":"Fernandes GC et al (2007) Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de fora, Brazil, 1999-2005. Vaccine 25(16):3124\u20133128. https:\/\/doi.org\/10.1016\/j.vaccine.2007.01.078","journal-title":"Vaccine"},{"issue":"10","key":"2_CR43","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","volume":"25","author":"AW McMahon","year":"2007","unstructured":"McMahon AW et al (2007) Yellow fever working group. Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. Vaccine 25(10):1727\u20131734. https:\/\/doi.org\/10.1016\/j.vaccine.2006.11.027","journal-title":"Vaccine"},{"issue":"30","key":"2_CR44","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1016\/j.vaccine.2005.03.002","volume":"23","author":"E Massad","year":"2005","unstructured":"Massad E et al (2005) Yellow fever vaccination: how much is enough? Vaccine 23(30):3908\u20133914. https:\/\/doi.org\/10.1016\/j.vaccine.2005.03.002","journal-title":"Vaccine"},{"issue":"7","key":"2_CR45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMp1803433","volume":"379","author":"K Vannice","year":"2018","unstructured":"Vannice K, Wilder-Smith A, Hombach J (2018) Fractional-dose yellow fever vaccination \u2013 advancing the evidence base. N Engl J Med 379(7):603\u2013605. https:\/\/doi.org\/10.1056\/NEJMp1803433","journal-title":"N Engl J Med"},{"key":"2_CR46","unstructured":"Minist\u00e9rio da Sa\u00fade (Brazil) (2014) Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. Manual de Vigil\u00e2ncia Epidemiol\u00f3gica de Eventos Adversos P\u00f3s-Vacina\u00e7\u00e3o (3rd ed.). Bras\u00edlia, Minist\u00e9rio da Sa\u00fade"}],"container-title":["Methods in Molecular Biology","Yellow Fever Virus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4458-4_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:36:42Z","timestamp":1744951002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4458-4_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071644577","9781071644584"],"references-count":46,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4458-4_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"19 April 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}